RB
Regina Barzilay
Member Board Of Directors at Dewpoint Therapeutics
Cambridge, Massachusetts
Overview
Regina Barzilay is a Professor of Electrical Engineering and Computer Science at MIT with a strong background in academia and industry collaborations, currently serving on the board of directors for Dewpoint Therapeutics and as a scientific advisory board member for Immunai and Johnson & Johnson's Janssen R&D division. She holds a Doctor of Philosophy from Columbia University and has made significant contributions to the fields of data services and artificial intelligence throughout her career.
Work Experience
Professor of Electrical Engineering and Computer Science
2003 - Current
Member Board Of Directors
2020
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
Raised $287,000,000.00 from SoftBank Vision Fund, Mirae Asset Capital, Polaris Partners, General Catalyst, Leaps by Bayer, Maverick Ventures, ARCH Venture Partners, NS Investment, Samsara BioCapital and 3E Bioventures.
SAB member
2019
Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.
Raised $295,000,000.00 from Piedmont Capital Investments, Alexandria Venture Investments, Koch Disruptive Technologies, 8VC, ICon, Meron Capital and Talos VC.
SAB member, Janssen R&D
2018
Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.